Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,773 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,526)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00813332 | Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 4 | 300 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 25, 2010 | clinicaltrials |
| NCT01051362 | Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 48 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 18, 2010 |
| clinicaltrials |
| NCT00516100 | Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC | unknown | Phase 1 / Phase 2 | 62 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01048970 | Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 14, 2010 | clinicaltrials |
| NCT00997724 | Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer(VATS) | unknown | Phase 2 | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT01041833 | Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker | unknown | Phase 3 | 230 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 1, 2010 | clinicaltrials |
| NCT01028729 | A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)(NSCLC) | unknown | Phase 4 | 120 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00752076 | Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment(EGFR) | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | Dec 1, 2009 | clinicaltrials |
| NCT01019798 | Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer | unknown | Phase 2 | 16 | Taipei Medical University HospitalOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT01003522 | Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer(RESTORE-AIR) | unknown | Phase 3 | 60 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 28, 2009 | clinicaltrials |
| NCT01000428 | The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer | unknown | — | 34 | Asan Medical CenterOTHER | 1 | Oct 27, 2009 | clinicaltrials |
| NCT00982605 | EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN) | unknown | — | 50 | Heidelberg UniversityOTHER | 1 | Oct 6, 2009 | clinicaltrials |
| NCT00568841 | Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)(ERLOPET) | unknown | Phase 2 | 40 | Lung Cancer Group CologneOTHER | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00964132 | Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 48 | NuRx Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 3, 2009 | clinicaltrials |
| NCT00801385 | Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy | unknown | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00786331 | Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC | unknown | Phase 2 | 230 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00938418 | Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 43 | National University Hospital, SingaporeOTHER | 1 | Jul 13, 2009 | clinicaltrials |
| NCT00935571 | Incidence of Postthoracotomy Pain Following General Anesthesia: A Comparison Between TIVA and Inhalation Anesthesia | unknown | — | 400 | Asan Medical CenterOTHER | 1 | Jul 9, 2009 | clinicaltrials |
| NCT00300729 | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy(CYCLUS) | unknown | Phase 3 | 319 | University Hospital, LinkoepingOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00923637 | Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer | unknown | Phase 2 | 75 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 18, 2009 | clinicaltrials |
| NCT00908336 | Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen | unknown | Phase 2 | 70 | Hospital Arnau de VilanovaOTHER | 1 | May 25, 2009 | clinicaltrials |
| NCT00905983 | Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 48 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00906061 | Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 76 | Hospital Arnau de VilanovaOTHER | 1 | May 21, 2009 | clinicaltrials |
| NCT00173524 | PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | May 19, 2009 | clinicaltrials |
| NCT00903292 | Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma | unknown | N/A | 52 | National Cheng-Kung University HospitalOTHER | 1 | May 18, 2009 | clinicaltrials |
| NCT00886028 | Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma | unknown | Phase 2 | 31 | National Institute of CancerologíaOTHER_GOV | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse(SPEAR) | unknown | Phase 3 | 399 | Poniard PharmaceuticalsINDUSTRY | 15 | Apr 14, 2009 | clinicaltrials |
| NCT00880945 | Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions | unknown | — | 40 | Azienda Ospedaliero Universitaria Maggiore della CaritaOTHER | 1 | Apr 14, 2009 | clinicaltrials |
| NCT00006347 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00006458 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00722969 | Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 48 | Universitair Ziekenhuis BrusselOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00675168 | Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice(PROLOG) | unknown | Phase 4 | 1,700 | Odense University HospitalOTHER | 1 | Feb 19, 2009 | clinicaltrials |
| NCT00845143 | Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer | unknown | — | 100 | Heidelberg UniversityOTHER | 0 | Feb 18, 2009 | clinicaltrials |
| NCT00846443 | Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer | unknown | Phase 1 | 12 | Fudan UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | unknown | Phase 3 | 280 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00006087 | Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer | unknown | N/A | — | Jewish Hospital and St. Mary's HealthcareOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00077220 | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00270582 | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer | unknown | Phase 2 | 58 | Far Eastern Memorial HospitalOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00274898 | Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer | unknown | Phase 2 | 80 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00616499 | Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | unknown | Phase 2 | 35 | Yonsei UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00616785 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | unknown | Phase 2 | 41 | Yonsei UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00828022 | Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer(SMC4692) | unknown | Phase 1 / Phase 2 | 15 | Soroka University Medical CenterOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00815971 | Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib | unknown | — | 300 | Aarhus University HospitalOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00497250 | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy | unknown | Phase 1 | 32 | Fudan UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00546130 | Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer(RNCLC) | unknown | Phase 2 | 45 | University of ToyamaOTHER | 1 | Sep 3, 2008 | clinicaltrials |
| NCT00727350 | Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. | unknown | Phase 2 | 44 | Universitair Ziekenhuis BrusselOTHER | 1 | Aug 4, 2008 | clinicaltrials |
| NCT00006116 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00014547 | BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075517 | Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00184964 | Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis | unknown | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Jun 4, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jan 25, 2010source: clinicaltrials